BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17667218)

  • 1. Enoxaparin-induced skin necrosis: a fatal outcome.
    Singh S; Verma M; Bahekar A; Agrawal P; Duggal J; Iliescu M; Khosla P; Muzaffar S
    Am J Ther; 2007; 14(4):408-10. PubMed ID: 17667218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fatal case of enoxaparin induced skin necrosis and thrombophilia.
    Nadir Y; Mazor Y; Reuven B; Sarig G; Brenner B; Krivoy N
    Eur J Haematol; 2006 Aug; 77(2):166-8. PubMed ID: 16856910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia.
    Imberti D; Vallisa D; Anselmi E; Moroni CF; Bertè R; Lazzaro A; Bernuzzi P; Arcari AL; Cavanna L
    Tumori; 2004; 90(4):390-3. PubMed ID: 15510981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies.
    Tonn ME; Schaiff RA; Kollef MH
    Ann Pharmacother; 1997 Mar; 31(3):323-6. PubMed ID: 9066940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous pectoral hematoma secondary to enoxaparin for the treatment of deep venous thrombosis in an elderly man.
    Ozpolat B; Yazkan R; Aksoy M; Doğan S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):E40. PubMed ID: 19103532
    [No Abstract]   [Full Text] [Related]  

  • 6. Rare presentation of enoxaparin-induced skin necrosis in a postoperative patient.
    Byrne EM; Khattab A; Chen F; Bhagavatula R
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35418382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dermal necrosis as cutaneous manifestation of heparin-induced thrombocytopenia II?].
    Illes M; Klaus S; Simon JC; Treudler R
    Hautarzt; 2011 Apr; 62(4):290-2. PubMed ID: 20835809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of warfarin skin necrosis despite enoxaparin anticoagulation in a patient with protein S deficiency.
    Tai CY; Ierardi R; Alexander JB
    Ann Vasc Surg; 2004 Mar; 18(2):237-42. PubMed ID: 15253263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep venous thrombosis: outpatient therapy with low-molecular-weight heparin.
    Tapson VF
    Manag Care; 1999 Dec; 8 Suppl():2-6. PubMed ID: 11729399
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation: cascade!
    Olah Z; Bereczky Z; Szarvas M; Boda Z
    Lancet; 2011 Aug; 378(9792):740. PubMed ID: 21856488
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-molecular-weight heparin-induced thrombocytopenia in a child.
    Dager WE; White RH
    Ann Pharmacother; 2004 Feb; 38(2):247-50. PubMed ID: 14742760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of HIT antibody complex in hip fracture patients receiving enoxaparin or unfractionated heparin.
    Griffin JW; Hopkinson WJ; Lassen MR; Thethi I; Litinas E; Fareed J
    Clin Appl Thromb Hemost; 2011; 17(6):567-71. PubMed ID: 22345625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enoxaparin induced skin necrosis].
    Scharf Y; Hershkoviz R
    Harefuah; 2003 Nov; 142(11):742-3, 807. PubMed ID: 14631903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 71-year-old man with a hemorrhagic vesicular eruption.
    Hamilton CE; King BA; Cowper SE; Hochster H; Leventhal JS
    Int J Dermatol; 2018 Feb; 57(2):147-148. PubMed ID: 29057466
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enoxaparin-induced hepatotoxicity].
    Zaera De La Fuente C; Arribas Anta J; López-San Román A; Cañete Ruiz Á; López Durán S
    Gastroenterol Hepatol; 2015; 38(7):438-9. PubMed ID: 25155866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Headaches in a 21-year-old man with Goodpasture disease].
    Petit JS; Murat O; Perrier S; Lepouse C; Jaussaud M; Léon A
    Ann Fr Anesth Reanim; 2009 Sep; 28(9):799-802. PubMed ID: 19682834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Infarction with Limb Arterial and Venous Thrombosis in a Patient with Enoxaparin-Induced Thrombocytopenia.
    Singh N; Singh Lubana S; Tsai HM
    Am J Case Rep; 2020 May; 21():e922498. PubMed ID: 32469847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.
    Lynd LD; Goeree R; Crowther MA; O'Brien BJ
    Can J Clin Pharmacol; 2007; 14(2):e215-26. PubMed ID: 17652767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.